Top Page
Welcia Holdings Co., Ltd.
(3141)
Welcia Holdings Co., Ltd. (3141) vs. iShares MSCI Japan ETF (EWJ)
Welcia Holdings Co., Ltd. Business Overview & Revenue Model
Welcia Holdings Co., Ltd. Financial Statement Overview
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.26T | 1.29T | 1.22T | 1.14T | 1.03T | 949.65B |
| Gross Profit | 378.68B | 364.42B | 370.11B | 349.25B | 320.94B | 296.05B |
| EBITDA | 56.37B | 53.31B | 65.45B | 68.86B | 61.98B | 59.95B |
| Net Income | 20.85B | 14.96B | 26.45B | 27.03B | 26.45B | 28.00B |
Balance Sheet | ||||||
| Total Assets | 632.02B | 579.99B | 551.86B | 537.36B | 463.05B | 435.69B |
| Cash, Cash Equivalents and Short-Term Investments | 71.63B | 35.01B | 30.53B | 32.85B | 23.40B | 51.92B |
| Total Debt | 82.80B | 81.25B | 82.70B | 86.07B | 62.51B | 47.55B |
| Total Liabilities | 378.50B | 325.50B | 307.50B | 304.98B | 255.16B | 255.34B |
| Stockholders Equity | 247.29B | 248.62B | 237.71B | 225.91B | 201.78B | 179.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 37.23B | 28.17B | 40.49B | -3.92B | 31.93B |
| Operating Cash Flow | 0.00 | 47.84B | 46.53B | 60.30B | 16.23B | 46.40B |
| Investing Cash Flow | 0.00 | -22.74B | -22.03B | -36.07B | -37.09B | -16.15B |
| Financing Cash Flow | 0.00 | -20.77B | -26.81B | -14.85B | -7.28B | -16.97B |
Welcia Holdings Co., Ltd. Technical Analysis
Welcia Holdings Co., Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥525.92B | 34.92 | 1.43% | 5.56% | -43.50% | ||
51 Neutral | $7.55B | 0.30 | -61.90% | 2.27% | 17.11% | 1.58% | |
| $3.66B | 18.13 | 11.61% | 0.02% | ― | ― | ||
| $4.34B | 24.46 | 10.45% | 1.22% | ― | ― | ||
| $3.80B | 18.71 | 4.93% | 0.04% | ― | ― | ||
78 Outperform | ¥201.35B | 14.48 | 311.25% | 8.98% | 0.10% | ||
78 Outperform | ¥384.86B | 20.16 | 0.38% | 13.86% | 98.99% |
Welcia Holdings Co., Ltd. Corporate Events
Welcia Holdings Co., Ltd. announced a proposal to amend its Articles of Incorporation to accommodate the diversification of its business activities. The amendments include expanding its business purposes to cover welfare services for persons with disabilities, in-home nursing, health guidance, and transportation services, reflecting the company’s strategic shift towards broader healthcare and support services.
The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1800.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.
Welcia Holdings Co., Ltd. announced details regarding its controlling shareholder, AEON Co., Ltd., which owns a significant portion of its voting rights. Despite this, Welcia maintains operational independence and emphasizes protecting the interests of its shareholders by appointing a majority of independent directors. The company has outlined its transactions with AEON, including consumption deposits and royalty payments, ensuring terms are fairly determined.
The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1950.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.
Welcia Holdings Co., Ltd. announced corrections to previously disclosed supplementary materials for the fiscal year ended February 2025 and the third quarter of the fiscal year ending February 2025. These corrections pertain to management indexes, the number of stores, store space, and sales per unit. The updated materials have been made available on the company’s website, reflecting the company’s commitment to transparency and accuracy in its financial reporting, which is crucial for maintaining stakeholder trust and ensuring informed decision-making.
The most recent analyst rating on (JP:3141) stock is a Hold with a Yen2300.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.
Welcia Holdings Co., Ltd. announced a significant change in its leadership, with the resignation of Representative Director, Chairman, and CEO Takamitsu Ikeno, effective after the upcoming shareholders’ meeting. This move is part of the company’s strategy to adapt to complex market changes by transitioning to a management structure led by younger leaders, with Hideaki Kirisawa becoming the sole representative director.
Welcia Holdings Co., Ltd. announced its financial results for the fiscal year ended February 2025, highlighting its strategic vision to become the community’s top health station by 2030. The briefing included details on financial achievements, store operations, and future earnings forecasts, indicating a focus on expanding its market presence and enhancing service offerings.
Welcia Holdings Co., Ltd. and Tsuruha Holdings Inc. have entered into a share exchange agreement as part of a business integration plan, making Tsuruha the parent company and Welcia a subsidiary. This integration aims to address challenges in the drugstore industry, such as drug price reductions and rising costs, while promoting equal access to health services and enhancing their market position.
Welcia Holdings Co., Ltd. is set to undergo a significant change in its corporate structure with a planned share exchange with Tsuruha Holdings Inc., making Tsuruha the new parent company and largest major shareholder. This strategic move, effective December 1, 2025, will see AEON Co., Ltd. cease to be the largest shareholder, although it plans to maintain its parent company status through a tender offer to retain a 50.9% voting rights ratio in Tsuruha Holdings.
Welcia Holdings Co., Ltd., along with AEON Co., Ltd. and Tsuruha Holdings Inc., has entered into a definitive agreement for a capital and business alliance. This alliance aims to address regional disparities in medical and health services in Japan, particularly in rural areas, by leveraging economies of scale and combining store networks, expertise, and logistics systems. The integration seeks to meet the growing demand for comprehensive drugstore services, including medical and nursing care, by developing new business categories and opening new stores.
Welcia Holdings Co., Ltd. announced it will record an extraordinary loss of ¥13.1 billion for the fiscal year ended February 28, 2025, due to an impairment loss from noncurrent assets at some subsidiary-operated stores. This decision reflects a decline in profitability from a challenging business environment, impacting the company’s financial results as disclosed in their consolidated financial statements.
Welcia Holdings Co., Ltd. reported its consolidated financial results for the fiscal year ended February 28, 2025, showing a 5.6% increase in net sales to 1,285,005 million yen. However, the company experienced a decline in operating and ordinary income by 15.8% and 14.5%, respectively, with net income attributable to owners of the parent falling by 43.5%. The company plans to integrate with TSURUHA Holdings Inc. and delist on November 27, 2025, which may significantly impact its market positioning and operations.